Leqembi (lecanemab-irmb) – Medical Benefit Coverage Criteria
Customize your policy alerts
Sign up for sierra health and life Policy 2026D0125D alerts
Get alerted when Policy 2026D0125D changes without checking for updates manually.
Monitor payer policy activity
Covers medical-benefit administration of intravenous Leqembi for members when criteria for treatment of early Alzheimer's disease are met; distinguishes formulation obtained under pharmacy benefit. Affects prescribers and prior authorization reviewers.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.